Italy Suspends AstraZeneca’s COVID Vaccine After Teen’s Brain Hemorrhage Death
The government of Italy has suspended AstraZeneca/Oxford University’s experimental AZD1222 COVID-19 vaccine for people under 60 years of age in that country. The decision, announced on June 11, 2021, follows the recent death of 18-year-old Camilla Canepa, who died of a cerebral due to a blood clot 16 days after receiving the first dose of […]
NIH Begins Testing Mixed COVID-19 Vaccine Schedules
The U.S. National Institutes of Health (NIH) has announced that it has begun an early stage Phase 1/2 clinical trial to examining what happens when an adult who is fully vaccinated with one type of COVID-19 vaccine, is given a different booster vaccine from another manufacturer three to four months later.1 Currently, there are three […]
Probable Link Found Between Pfizer’s COVID Shot and Heart Inflammation
On June 2, 2021, the Israeli Ministry of Health announced that it believes there is a “probable link” between Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 and dozens of cases of myocarditis (inflammation of the heart) in Israel—mostly in males between 16-30 years of age. According to an epidemiological study undertaken by a […]
CDC Investigating Cases of Heart Inflammation After COVID-19 Vaccination
The U.S. Centers for Disease Control and Prevention (CDC) has begun an investigation into reports of myocarditis (heart inflammation) in people between 16 and 45 years of age after receiving either the genetically engineered experimental messenger ribonucleic acid (mRNA) BNT162b2 and mRNA-1273 biologics for COVID-19 developed by Pfizer/BioNTech and Moderna/National Institute of Allergy and Infectious […]
Millions of Americans Decline Second Dose of Experimental mRNA COVID-19 Vaccines
By the end of April 2021, more than five million people in the United States, or about eight percent of the population, had not received the second dose of the experimental mRNA Pfizer/BioNTech or Moderna/NIAID COVID-19 vaccines being distributed under an Emergency Use Authorization (EUA) granted by the U.S. Food and Drug Administration (FDA).
OSHA Revises Employer Guidelines on COVID Vaccine Reactions to Avoid “Appearance” of Discouraging Vaccination
As an increasing number of employers including restaurants, colleges and health care facilities are requiring the COVID-19 vaccine, many employers are looking to the federal Occupational Safety and Hazard Administration (OSHA), among other government agencies, for guidance on how to proceed with COVID-19 vaccination protocols.